Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 24, 2015 - Issue 7
Submit an article Journal homepage
460
Views
16
CrossRef citations to date
0
Altmetric
Drug Evaluation

Romidepsin for the treatment of non-Hodgkin’s lymphoma

Victor Y YazbeckVirginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA;Virginia Commonwealth University, Department of Internal Medicine, Richmond, VA, USA
&
Steven GrantVirginia Commonwealth University, Massey Cancer Center, Richmond, VA, USA;Virginia Commonwealth University, Department of Internal Medicine, Richmond, VA, USA;Virginia Commonwealth University, Department of Microbiology and Immunology, Richmond, VA, USA;Virginia Commonwealth University, Department of Biochemistry and Molecular Biology, Richmond, VA, USA;Virginia Commonwealth University, Department of Human and Molecular Genetics, Richmond, VA, USA;Virginia Commonwealth University, Institute for Molecular Medicine, 401 College Street, P.O. Box 980035, Richmond, VA 23298, USA+1 804 828 5211; [email protected]
Pages 965-979 | Published online: 04 May 2015

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cristiana Libardi Miranda Furtado, Maria Claudia Dos Santos Luciano, Renan Da Silva Santos, Gilvan Pessoa Furtado, Manoel Odorico Moraes & Claudia Pessoa. (2019) Epidrugs: targeting epigenetic marks in cancer treatment. Epigenetics 14:12, pages 1164-1176.
Read now
Prithviraj Bose & Srdan Verstovsek. (2016) Investigational histone deacetylase inhibitors (HDACi) in myeloproliferative neoplasms. Expert Opinion on Investigational Drugs 25:12, pages 1393-1403.
Read now

Articles from other publishers (14)

Shuhui Zhuang, Zhaobo Yang, Zhuangzhuang Cui, Yuanyuan Zhang & Fengyuan Che. (2023) Epigenetic alterations and advancement of lymphoma treatment. Annals of Hematology.
Crossref
Dandan Song, Yan Lian & Lin Zhang. (2023) The potential of activator protein 1 (AP-1) in cancer targeted therapy. Frontiers in Immunology 14.
Crossref
Peipei Yang, Yali Tao, Ailin Zhao, Kai Shen, He Li, Jinjin Wang, Hui Zhou, Zhongwang Wang, Mengyao Wang, Ying Qu, Li Zhang, Yuhuan Zheng & Ting Niu. (2023) Efficacy and safety of histone deacetylase inhibitors in peripheral T-cell lymphoma: a systematic review and meta-analysis on prospective clinical trials. Frontiers in Oncology 13.
Crossref
Mengshu You, Zhuolin Xie, Nan Zhang, Yixuan Zhang, Desheng Xiao, Shuang Liu, Wei Zhuang, Lili Li & Yongguang Tao. (2023) Signaling pathways in cancer metabolism: mechanisms and therapeutic targets. Signal Transduction and Targeted Therapy 8:1.
Crossref
Eliza Mari Kwesi-Maliepaard, Muddassir Malik, Tibor van Welsem, Remco van Doorn, Maarten H. Vermeer, Hanneke Vlaming, Heinz Jacobs & Fred van Leeuwen. (2022) DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro. Frontiers in Genetics 13.
Crossref
Eftiola Pojani & Daniela Barlocco. (2021) Romidepsin (FK228), A Histone Deacetylase Inhibitor and its Analogues in Cancer Chemotherapy. Current Medicinal Chemistry 28:7, pages 1290-1303.
Crossref
Magdalena Rausch, Andrea Weiss, Marloes Zoetemelk, Sander R. Piersma, Connie R. Jimenez, Judy R. van Beijnum & Patrycja Nowak-Sliwinska. (2020) Optimized Combination of HDACI and TKI Efficiently Inhibits Metabolic Activity in Renal Cell Carcinoma and Overcomes Sunitinib Resistance. Cancers 12:11, pages 3172.
Crossref
Josiah D. Smith, Leah N. Cardwell, David Porciani, Andrea Nolla, Brenna T. Cornelison, Megan C. Schulte, Fabio Gallazzi, Donald H. Burke, Mark A. Daniels & Bret D. Ulery. (2020) Therapeutic peptide delivery via aptamer-displaying, disulfide-linked peptide amphiphile micelles . Molecular Systems Design & Engineering 5:1, pages 269-283.
Crossref
Kajal Thapa, Savir Kumar, Anurag Sharma, Sandeep Arora, Amarjot Kaur Grewal & Thakur Gurjeet Singh. (2019) Histone Deacetylase Inhibitors As Potential Therapeutic Agents For Various Disorders. Journal of Pharmaceutical Technology, Research and Management 5:2, pages 235-253.
Crossref
Yuan Wang, Guo-Hui Wan, Ying-Min Wu, Hong-Sheng Wang, Hai-Fang Wang, Ge Zhang, Lin-Lin Lu, Zi-Qian Li, Ka-Ying Chan, Yan Zhou, Shao-Hui Cai, Yi-Fei Qi & Jun Du. (2018) AP-1 confers resistance to anti-cancer therapy by activating XIAP. Oncotarget 9:18, pages 14124-14137.
Crossref
Jin Li, Changgeng Qian, Qianqian Zhou, Jiwei Li, Kunlun Li & Pingyong Yi. (2017) RETRACTED: BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma. Biochemical and Biophysical Research Communications 491:4, pages 939-945.
Crossref
H Ding, K L Peterson, C Correia, B Koh, P A Schneider, G S Nowakowski & S H Kaufmann. (2016) Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells. Leukemia 31:7, pages 1593-1602.
Crossref
Tian-Yun Wang, Yu-Rong Chai, Yan-Long Jia, Jian-Hui Gao, Xiao-Jun Peng & Hua-Feng Han. (2016) Crosstalk among the proteome, lysine phosphorylation, and acetylation in romidepsin-treated colon cancer cells. Oncotarget 7:33, pages 53471-53501.
Crossref
Anne C. Mirabella, Benjamin M. Foster & Till Bartke. (2015) Chromatin deregulation in disease. Chromosoma 125:1, pages 75-93.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.